5-MeO-MiPT explained

5-MeO-MiPT is a psychedelic and hallucinogenic drug, used by some as an entheogen. It has structural and pharmacodynamic properties similar to the drugs 5-MeO-DiPT, DiPT, and MiPT. It is commonly used as a "substitute" for 5-MeO-DiPT because of the very similar structure and effects.

Chemistry

5-MeO-MiPT is in a class of compounds commonly known as tryptamines, and is the N-methyl-N-isopropyl homologue of the psychedelic, 5-MeO-DMT. The full name of the chemical is 5-methoxy-N-methyl-N-isopropyltryptamine.

5-MeO-MiPT causes the ehrlich reagent to turn purple then fade to faint blue. It causes the marquis reagent to go yellow through to black.[1]

Effects

This is an analogue of the more popular drug 5-MeO-DiPT (nicknamed "foxy methoxy") and has the nickname "moxy". Some users report the tactile effects of 5-MeO-DiPT without some of the unwanted side effects. At higher doses it becomes much more psychedelic sometimes being compared to 5-MeO-DMT. But at doses of 4-10 milligrams users find 5-MeO-MiPT to be a very euphoric and tactile chemical.[2] [3] Its energetic effects can be very strong at high doses, increasing normal heart rate considerably. Sounds can be amplified in perception to a point where synesthetic effects ("touching or/and tasting sounds") occur.[4]

Pharmacodynamics

Binding SitesBinding Affinity Ki (μM)[5]
5-HT1A0.058
5-HT2A0.163
5-HT2C1.3
D1>25
D2>25
D3>25
α1A>12
α2A5.3
TAAR1>15
H13.9
SERT3.3
DAT>26
NET>22

Dosage

Based on Shulgin's personal experience.[6] dosage for an adult male of approximately 6' and 200lbs:

DOSAGE: 4 - 6 mg, orally; 12 - 20 mg, smoked

DURATION : 4 - 6 hrs

Pharmacology

The mechanism that produces the hallucinogenic and entheogenic effects of 5-MeO-MiPT is thought to result primarily from 5-HT2A receptor agonism, although additional mechanisms of action such as inhibition of MAO may be involved also.[7] [8] While 5-MeO-MiPT binds most strongly to 5-HT1A receptors, it also shows fairly strong binding affinity to the SERT and NET, thereby acting as a moderately potent serotonin-norepinephrine reuptake inhibitor.[9] These mechanisms may help explain why there are many anecdotal reports of anti-depressant and anxiolytic effects from modest doses of this compound. For example, SNRIs such as venlafaxine are commonly prescribed to treat depression, and the 5-HT1A agonist buspirone is prescribed primarily for treatment of anxiety.

Reagent Results

Exposing compounds to the reagents gives a colour change which is indicative of the compound under test. The following test results are from protestkit.

5-MeO-MiPTMarquisMeckeMandelinLiebermannEhrlichHofmannSimon’s
FreebaseOrange to brownOrange redDeep greenish brownUnknownPurpleNo reactionNo reaction
HClOrange to brownRed to brownGreenish brown BrownViolet to purple GreenUnknown

Dangers

The toxicity of 5-MeO-MiPT is not known. There is no known documentation of death attributed to the use of 5-MeO-MiPT alone.

Legal status

Canada

5-MeO-MiPT is not scheduled in Canada.

China

As of October 2015 5-MeO-MiPT is a controlled substance in China.[10]

Finland

Scheduled in government decree on psychoactive substances banned from the consumer market.[11]

Luxembourg

In Luxembourg, 5-MeO-MiPT is not cited in the list of prohibited substances.[12] Therefore, it is still a legal substance.

United Kingdom

5-MeO-MiPT is a Class A drug in the United Kingdom as are most ethers of ring-hydroxy tryptamines.

United States

5-MeO-MiPT is unscheduled at the federal level in the United States,[13] but it could be considered an analog of 5-MeO-DiPT, in which case purchase, sale, or possession with intent to consume could be prosecuted under the Federal Analog Act.

Florida

"5-Methoxy-N-methyl-N-isopropyltryptamine" is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in the state of Florida.[14]

See also

External links

Notes and References

  1. Analytical Profiles for Five "Designer" Tryptamines . Microgram Journal . 2004 . Spratley T . 3 . 1–2 . 55 . PDF . 2013-10-09 .
  2. Web site: Carpenter DE . 2022-01-25. DEA Proposes Adding Five Psychedelic Compounds to Schedule 1. 2022-01-26. Lucid News. en-US.
  3. Palamar JJ, Acosta P . A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines . Human Psychopharmacology . 35 . 1 . e2719 . January 2020 . 31909513 . 6995261 . 10.1002/hup.2719 .
  4. Web site: 5-MeO-MiPT . 2022-11-16 . The Drug Classroom . en-US.
  5. Rickli A, Moning OD, Hoener MC, Liechti ME . Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens . European Neuropsychopharmacology . 26 . 8 . 1327–1337 . August 2016 . 27216487 . 10.1016/j.euroneuro.2016.05.001 . 6685927 .
  6. Web site: Erowid Online Books : "TIHKAL" .
    1. 40 5-MEO-MIPT
    . 2021-06-01 .
  7. Repke DB, Grotjahn DB, Shulgin AT . Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents . Journal of Medicinal Chemistry . 28 . 7 . 892–896 . July 1985 . 4009612 . 10.1021/jm00145a007 .
  8. Nagai F, Nonaka R, Satoh Hisashi Kamimura K . The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain . European Journal of Pharmacology . 559 . 2–3 . 132–137 . March 2007 . 17223101 . 10.1016/j.ejphar.2006.11.075 .
  9. Ray TS . Psychedelics and the human receptorome . PLOS ONE . 5 . 2 . e9019 . February 2010 . 20126400 . 2814854 . 10.1371/journal.pone.0009019 . free . 2010PLoSO...5.9019R .
  10. Web site: 关于印发《非药用类麻醉药品和精神药品列管办法》的通知 . Notice on Printing and Distributing the "Measures for the Scheduling of Non-Pharmaceutical Narcotic Drugs and Psychotropic Substances" . China Food and Drug Administration . 27 September 2015 . zh . 1 October 2015 . https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html . 1 October 2015 . dead .
  11. Web site: FINLEX ® - Säädökset alkuperäisinä: Valtioneuvoston asetus kuluttajamarkkinoilta… 1130/2014. www.finlex.fi. 11 July 2023.
  12. Web site: Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie . Law of February 19, 1973 concerning the sale of medicinal substances and the fight against drug addiction . fr . Journal officiel du Grand-Duché de Luxembourg . Official Journal of the Grand Duchy of Luxembourg .
  13. Web site: 21 CFR — SCHEDULES OF CONTROLLED SUBSTANCES §1308.11 Schedule I. . 2014-12-17 . 2009-08-27 . https://web.archive.org/web/20090827043725/http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_11.htm . dead .
  14. Web site: Chapter 893 - Drug Abuse Prevention and Control . Florida Statutes .